Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization

Gui Lee, Woo Yang, Hei Jeung, Sang Kim, Min Seo, Chan Park, Hyuncheol Chung, SunYoung Rha

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Thymoma is a heterogeneous group of tumors in biology and clinical behavior. Even though thymoma is divided into five subgroups following the World Health Organization classification, the nature of the disease is mixed within the subgroups. Results: We investigated the molecular characteristics of genetic changes variation of thymoma using cDNA microarray based-comparative genomic hybridization (CGH) with a 17 K cDNA microarray in an indirect, sex-matched design. Genomic DNA from the paraffin embedded 39 thymoma tissues (A 6, AB 11, B1 7, B2 7, B3 8) labeled with Cy-3 was co-hybridized with the reference placenta gDNA labeled with Cy-5. Using the CAMVS software, we investigated the deletions on chromosomes 1, 2, 3, 4, 5, 6, 8, 12, 13 and 18 throughout the thymoma. Then, we evaluated the genetic variations of thymoma based on the subgroups and the clinical behavior. First, the 36 significant genes differentiating five subgroups were selected by Significance Analysis of Microarray. Based on these genes, type AB was suggested to be heterogeneous at the molecular level as well as histologically. Next, we observed that the thymoma was divided into A, B (1, 2) and B3 subgroups with 33 significant genes. In addition, we selected 70 genes differentiating types A and B3, which differ largely in clinical behaviors. Finally, the 11 heterogeneous AB subtypes were able to correctly assign into A and B (1, 2) types based on their genetic characteristics. Conclusion: In our study, we observed the genome-wide chromosomal aberrations of thymoma and identified significant gene sets with genetic variations related to thymoma subgroups, which might provide useful information for thymoma pathobiology.

Original languageEnglish
Article number305
JournalBMC Genomics
Volume8
DOIs
Publication statusPublished - 2007 Sep 3

Fingerprint

Comparative Genomic Hybridization
Thymoma
Oligonucleotide Array Sequence Analysis
Genome
Genes
Chromosomes, Human, Pair 2
Chromosomes, Human, Pair 1
Microarray Analysis
Chromosome Aberrations
Paraffin
Placenta
Molecular Biology
Software

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Genetics

Cite this

@article{77e4589c097d431ab1e275049f8c5793,
title = "Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization",
abstract = "Background: Thymoma is a heterogeneous group of tumors in biology and clinical behavior. Even though thymoma is divided into five subgroups following the World Health Organization classification, the nature of the disease is mixed within the subgroups. Results: We investigated the molecular characteristics of genetic changes variation of thymoma using cDNA microarray based-comparative genomic hybridization (CGH) with a 17 K cDNA microarray in an indirect, sex-matched design. Genomic DNA from the paraffin embedded 39 thymoma tissues (A 6, AB 11, B1 7, B2 7, B3 8) labeled with Cy-3 was co-hybridized with the reference placenta gDNA labeled with Cy-5. Using the CAMVS software, we investigated the deletions on chromosomes 1, 2, 3, 4, 5, 6, 8, 12, 13 and 18 throughout the thymoma. Then, we evaluated the genetic variations of thymoma based on the subgroups and the clinical behavior. First, the 36 significant genes differentiating five subgroups were selected by Significance Analysis of Microarray. Based on these genes, type AB was suggested to be heterogeneous at the molecular level as well as histologically. Next, we observed that the thymoma was divided into A, B (1, 2) and B3 subgroups with 33 significant genes. In addition, we selected 70 genes differentiating types A and B3, which differ largely in clinical behaviors. Finally, the 11 heterogeneous AB subtypes were able to correctly assign into A and B (1, 2) types based on their genetic characteristics. Conclusion: In our study, we observed the genome-wide chromosomal aberrations of thymoma and identified significant gene sets with genetic variations related to thymoma subgroups, which might provide useful information for thymoma pathobiology.",
author = "Gui Lee and Woo Yang and Hei Jeung and Sang Kim and Min Seo and Chan Park and Hyuncheol Chung and SunYoung Rha",
year = "2007",
month = "9",
day = "3",
doi = "10.1186/1471-2164-8-305",
language = "English",
volume = "8",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",

}

Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. / Lee, Gui; Yang, Woo; Jeung, Hei; Kim, Sang; Seo, Min; Park, Chan; Chung, Hyuncheol; Rha, SunYoung.

In: BMC Genomics, Vol. 8, 305, 03.09.2007.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization

AU - Lee, Gui

AU - Yang, Woo

AU - Jeung, Hei

AU - Kim, Sang

AU - Seo, Min

AU - Park, Chan

AU - Chung, Hyuncheol

AU - Rha, SunYoung

PY - 2007/9/3

Y1 - 2007/9/3

N2 - Background: Thymoma is a heterogeneous group of tumors in biology and clinical behavior. Even though thymoma is divided into five subgroups following the World Health Organization classification, the nature of the disease is mixed within the subgroups. Results: We investigated the molecular characteristics of genetic changes variation of thymoma using cDNA microarray based-comparative genomic hybridization (CGH) with a 17 K cDNA microarray in an indirect, sex-matched design. Genomic DNA from the paraffin embedded 39 thymoma tissues (A 6, AB 11, B1 7, B2 7, B3 8) labeled with Cy-3 was co-hybridized with the reference placenta gDNA labeled with Cy-5. Using the CAMVS software, we investigated the deletions on chromosomes 1, 2, 3, 4, 5, 6, 8, 12, 13 and 18 throughout the thymoma. Then, we evaluated the genetic variations of thymoma based on the subgroups and the clinical behavior. First, the 36 significant genes differentiating five subgroups were selected by Significance Analysis of Microarray. Based on these genes, type AB was suggested to be heterogeneous at the molecular level as well as histologically. Next, we observed that the thymoma was divided into A, B (1, 2) and B3 subgroups with 33 significant genes. In addition, we selected 70 genes differentiating types A and B3, which differ largely in clinical behaviors. Finally, the 11 heterogeneous AB subtypes were able to correctly assign into A and B (1, 2) types based on their genetic characteristics. Conclusion: In our study, we observed the genome-wide chromosomal aberrations of thymoma and identified significant gene sets with genetic variations related to thymoma subgroups, which might provide useful information for thymoma pathobiology.

AB - Background: Thymoma is a heterogeneous group of tumors in biology and clinical behavior. Even though thymoma is divided into five subgroups following the World Health Organization classification, the nature of the disease is mixed within the subgroups. Results: We investigated the molecular characteristics of genetic changes variation of thymoma using cDNA microarray based-comparative genomic hybridization (CGH) with a 17 K cDNA microarray in an indirect, sex-matched design. Genomic DNA from the paraffin embedded 39 thymoma tissues (A 6, AB 11, B1 7, B2 7, B3 8) labeled with Cy-3 was co-hybridized with the reference placenta gDNA labeled with Cy-5. Using the CAMVS software, we investigated the deletions on chromosomes 1, 2, 3, 4, 5, 6, 8, 12, 13 and 18 throughout the thymoma. Then, we evaluated the genetic variations of thymoma based on the subgroups and the clinical behavior. First, the 36 significant genes differentiating five subgroups were selected by Significance Analysis of Microarray. Based on these genes, type AB was suggested to be heterogeneous at the molecular level as well as histologically. Next, we observed that the thymoma was divided into A, B (1, 2) and B3 subgroups with 33 significant genes. In addition, we selected 70 genes differentiating types A and B3, which differ largely in clinical behaviors. Finally, the 11 heterogeneous AB subtypes were able to correctly assign into A and B (1, 2) types based on their genetic characteristics. Conclusion: In our study, we observed the genome-wide chromosomal aberrations of thymoma and identified significant gene sets with genetic variations related to thymoma subgroups, which might provide useful information for thymoma pathobiology.

UR - http://www.scopus.com/inward/record.url?scp=36348998047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36348998047&partnerID=8YFLogxK

U2 - 10.1186/1471-2164-8-305

DO - 10.1186/1471-2164-8-305

M3 - Article

C2 - 17764580

AN - SCOPUS:36348998047

VL - 8

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

M1 - 305

ER -